Medical Devices Law & Industry Report provides complete in-depth, interdisciplinary news coverage of all major developments in the rapidly changing medical...
CHICAGO--Centers for Medicare & Medicaid Services policymakers rolling out the Physician Payments Sunshine Act June 17 attempted to soothe physicians' fears over potentially false or misleading reports pointing to dubious financial relationships with medical device and pharmaceutical manufacturers.
Anita Griner, CMS’s deputy director for the Data Sharing & Partnership Group, said data accuracy is the agency's top priority as it implements the Sunshine Act, created under Section 6002 of the Affordable Care Act. In line with that goal, Griner said CMS is creating a range of educational tools to orient stakeholders toward their compliance responsibilities.
Speaking to physicians attending the American Medical Association's House of Delegates meeting here, Griner also emphasized that medical professionals have the right to challenge data coming to CMS under the sunshine requirements if they think the information is false or misleading. She called on physicians to play an active role in the data accuracy process. Her comments were in response to concerns from several physicians that media outlets and consumer groups would attempt to “sensationalize’’ financial data published through the sunshine process.
“Data accuracy is the number one goal of our program,’’ Griner said. “We want the data put on the public website to be complete and accurate. We do not want it to be disputed. We do not want it to be inaccurate. We do not want to perpetuate any false information about a physician or teaching hospital. So data accuracy is key. And that will come from you tracking your own transfers and checking the website before it goes public.’’
Beginning Aug. 1, manufacturers of pharmaceuticals, medical devices, and biologicals will commence complying with the sunshine law's National Physician Payment Transparency Program, which CMS is calling OPEN PAYMENTS. The program requires companies to track items of value provided to physicians and teaching hospitals and submit annual reports on such activities. The data will be published annually as a strategy for preventing inappropriate influences on research, education, and clinical decisionmaking. In February, CMS published its final rule on physician payments transparency under the sunshine law (7 MELR 69, 2/6/13).
Dr. Shantanu Agrawal, director of CMS’s Data Sharing & Partnership Group, said three specific types of data must be reported to CMS:
• Covered manufacturers must report payments or other transfers of value (TOVs) made to physicians and teaching hospitals.
• Covered manufacturers and applicable group purchasing organizations (GPOs) must report certain ownership or investment interests held by physicians or their immediate family members.
• GPOs must report payments or other TOVs made to physician owners or investors if they held ownership or an investment interest at any point during a particular reporting year.
Griner said physicians do not have specific reporting requirements under the program. At the same time, she said physicians will have the right to check the information being supplied by manufacturers and GPOs and challenge inaccuracies prior to publication. Specifically, physicians will have 45 days to access the consolidated reports through an online portal. Disputed information will then undergo a resolution process.
Griner said CMS is creating several tools that will permit physicians to monitor the process, track transactions, and contest data inaccuracies. She pointed to fact pages and reporting explanations on the OPEN PAYMENTS website. Griner said CMS is also in the process of developing a free smart phone application that syncs with the reporting activities of the manufacturers.
AMA's outgoing president, Dr. Jeremy A. Lazarus, said the association supports efforts that provide the public with additional transparency over financial relationships between the medical profession and players in the health industry. At the same time, Lazarus said data accuracy is paramount.
“We want the law implemented appropriately and physician rights to challenge false or misleading reports protected,’’ Lazarus said in his June 15 address before the House of Delegates.
He noted that AMA has launched a Sunshine Act resource page to educate physicians on the law's requirements. He added that AMA will host online modules and webinars to provide physicians with further assistance.
Additional information about CMS’s OPEN PAYMENTS program is at http://www.cms.gov/Regulations-and-Guidance/Legislation/National-Physician-Payment-Transparency-Program/index.html.
The AMA's Sunshine Act resource page is at http://www.ama-assn.org/ama/pub/advocacy/topics/sunshine-act-and-physician-financial-transparency-reports.page.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)